Dengue - Pipeline Review, Q4 2010

Global Markets Direct
December 8, 2010
41 Pages - SKU: GMD6045828
Dengue - Pipeline Review, Q4 2010

Summary

Global Markets Direct’s, “Dengue Pipeline Review, Q4 2010”, provides an overview of the Dengue therapeutic pipeline. This report provides information on the therapeutic development for Dengue, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dengue. “Dengue-Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • A snapshot of the global therapeutic scenario for Dengue.
  • A review of the Dengue products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Dengue pipeline on the basis of therapeutic class, route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Identify and understand important and diverse types of therapeutics under development for Dengue.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Dengue pipeline depth and focus of Dengue therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.



More Infectious Diseases reports by Global Markets Direct

Polio - Pipeline Review, H2 2014 by Global Markets Direct
Polio - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Polio - Pipeline Review, H2 2014’, provides an overview of the Polio’s therapeutic pipeline.This report provides comprehensive ...
Bacterial Pneumonia - Pipeline Review, H2 2014 by Global Markets Direct
Bacterial Pneumonia - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Bacterial Pneumonia - Pipeline Review, H2 2014’, provides an overview of the Bacterial Pneumonia’s therapeutic pipeline.This ...
Yellow Fever - Pipeline Review, H2 2014 by Global Markets Direct
Yellow Fever - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Yellow Fever - Pipeline Review, H2 2014’, provides an overview of the Yellow Fever’s therapeutic pipeline.This ...
Typhoid Fever - Pipeline Review, H2 2014 by Global Markets Direct
Typhoid Fever - Pipeline Review, H2 2014SummaryGlobal Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H2 2014’, provides an overview of the Typhoid Fever’s therapeutic pipeline.This ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 500  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!